{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:41:48Z","timestamp":1770219708784,"version":"3.49.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The renin-angiotensin-aldosterone system (RAAS) is activated in states of decreased cardiac output and by certain cardiovascular therapeutic agents, such as loop diuretics and vasodilators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Short-term treatment with the inodilator, pimobendan, will not activate the circulating RAAS because its vasodilatory action will be offset by its positive inotropic property, thereby ameliorating RAAS stimulation at the juxtaglomerular apparatus. Furthermore, pimobendan will suppress RAAS activation produced by furosemide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Nine healthy laboratory dogs were used in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Experimental, cross-over study. Dogs were administered pimobendan (0.5\u2003mg\/kg q12h) for 4 days followed by furosemide (2\u2003mg\/kg q12h) and then, after a wash-out period, a combination of the drugs. Aldosterone\u2003:\u2003creatinine (A\u2003:\u2003Cr) was measured at the end of each treatment cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was no significant increase in the average urinary A\u2003:\u2003Cr with the administration of pimobendan (control urinary A\u2003:\u2003Cr = 0.46, standard deviation (SD) 0.33; pimobendan A\u2003:\u2003Cr = 0.48, SD 0.28). There was a significant increase in the average urinary A\u2003:\u2003Cr after administration of furosemide (urinary A\u2003:\u2003Cr = 1.3, SD 0.70) and with the combination of furosemide and pimobendan (urinary A\u2003:\u2003Cr = 2.9, SD 1.6).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Relevance<\/jats:title>\n                    <jats:p>Short-term administration of high-dose pimobendan, does not activate the RAAS in healthy dogs. Pimobendan did not prevent RAAS activation associated with furosemide therapy. These results in healthy dogs suggest that furosemide therapy, with or without pimobendan, should be accompanied by RAAS suppressive therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2009.0367.x","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T10:33:58Z","timestamp":1251801238000},"page":"1003-1006","source":"Crossref","is-referenced-by-count":28,"title":["Acute Effect of Pimobendan and Furosemide on the Circulating Renin-Angiotensin-Aldosterone System in Healthy Dogs"],"prefix":"10.1093","volume":"23","author":[{"given":"M.B.","family":"Sayer","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, NC"},{"name":"Carolina Veterinary Specialists , Charlotte, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Atkins","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Fujii","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, NC"},{"name":"Azabu University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Adams","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.C.","family":"DeFrancesco","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.W.","family":"Keene","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,9,1]]},"reference":[{"key":"2026020303112087400_b1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2460\/ajvr.2001.62.1793","article-title":"Additive effects of sodium and chloride restricted diets and furosemide administration in healthy dogs","volume":"62","author":"Lovern","year":"2001","journal-title":"Am J Vet Res"},{"key":"2026020303112087400_b2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0009-9236(01)49789-X","article-title":"Low sodium and furosemide-induced stimulation of the renin system in man mediated by cyclooxygenase2","volume":"70","author":"Kammerl","year":"2001","journal-title":"Clin Pharm Ther"},{"key":"2026020303112087400_b3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2885.2007.00894.x","article-title":"Effects of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin aldosterone system in the dog","volume":"30","author":"Atkins","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303112087400_b4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long term treatment with enalapril or hydralazine on the renin-angiotensin aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"Haggstrom","year":"1996","journal-title":"Am J Vet Res"},{"key":"2026020303112087400_b5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"key":"2026020303112087400_b6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"2026020303112087400_b7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cvsm.2004.05.018","article-title":"Use of pimobendan in the management of heart failure","volume":"34","author":"Luis-Fuentes","year":"2004","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303112087400_b8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5326\/0420090","article-title":"Pimobendan in heart failure therapy\u2014A silver bullet?","volume":"42","author":"Gordon","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303112087400_b9","first-page":"255","article-title":"A double-blind randomized placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy","volume":"16","author":"Luis-Fuentes","year":"2002","journal-title":"J Vet Int Med"},{"key":"2026020303112087400_b10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1748-5827.2005.tb00302.x","article-title":"Long-term efficacy of pimobendan in slight-to-moderate heart failure caused by myxomatous mitral valve disease in dogs. A prospective, single-blind, parallel, 6-month comparison with ramipril","volume":"46","author":"Smith","year":"2005","journal-title":"J Small Anim Pract"},{"key":"2026020303112087400_b11","first-page":"1124","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease","volume":"22","author":"H\u00e4ggstr\u00f6m","year":"2008","journal-title":"The QUEST study"},{"key":"2026020303112087400_b12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5326\/0420249","article-title":"Veterinary study for the confirmation of pimobendan in canine endocardiosis","volume":"42","author":"Lombard","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303112087400_b13","first-page":"1","article-title":"Estimation of 24-h aldosterone secretion in the dog, using urine aldosterone","volume":"9","author":"Gardner","year":"2007","journal-title":"creatinine"},{"key":"2026020303112087400_b14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the rennin-angiotensin-aldosterone system, atrial natriuretic peptide, and thyroid hormone concentrations in dogs","volume":"62","author":"Tidholm","year":"2001","journal-title":"Am J Vet Res"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2009.0367.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/5\/1003\/66653745\/j.1939-1676.2009.0367.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/5\/1003\/66653745\/j.1939-1676.2009.0367.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:11:32Z","timestamp":1770106292000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/23\/5\/1003\/8447164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,1]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2009.0367.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,9]]},"published":{"date-parts":[[2009,9,1]]}}}